| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
1 Development, Growth and Function Division, Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, UK, 2 Sustainable Livestock Systems Group, Scottish Agricultural College, Craibstone Estate, Bucksburn, Aberdeen AB21 9YA, UK and 3 School of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
Correspondence should be addressed to Cheryl J Ashworth at SAC; Email: c.ashworth{at}ab.sac.ac.uk
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In order to gain understanding of the factors associated with differential fetal growth, this study compared the fetoplacental unit associated with the smallest pig fetus in the uterus with a normally sized littermate. This permits assessment of local factors associated with fetal size, free from the confounding effects of maternal husbandry, genetic background and nutrition. Such studies are important for both the pig industry, where low birth weight is associated with significant loss, and for the human condition, as the pig is recognised as a valuable model to study low birth weight infants (Cooper 1975).
The capacity of the placenta to transport nutrients has a direct effect on fetal growth. We have demonstrated that placentas supplying the smallest fetus in the uterus are disproportionally lighter than those supplying average-sized fetuses in the same litter (Ashworth et al. 2001). These data, combined with the positive relationship between placental blood flow and fetal weight in the pig (Wootton et al. 1977), imply that there is a generalised reduction in the ability of placentas supplying small fetuses to deliver nutrients. In addition, there is increasing evidence in a variety of species, including rat, guinea pig, sheep and human, of an association between placental amino acid transport and fetal growth (reviewed in Sibley et al. 1997). Direct evidence for a role of placental amino acid transport in fetal growth comes from in vivo studies in sheep, where 13C-labelled leucine was infused during growth-retarded pregnancies and a reduction in maternal leucine flux into the placenta was observed (Ross et al. 1996). Further, abnormalities in amino acid transporter function have been observed in vesicles prepared from the microvillous membrane of the human placental syncytiotrophoblast associated with low birth weight babies (Dicke & Henderson 1988, Mahendran et al. 1993, Glazier et al. 1997, Jansson et al. 1998, Norberg et al. 1998).
This study tested the hypothesis that the capacity of the placenta to transport amino acids differs between placentas supplying inadequately grown and normally grown fetuses. Leucine was selected as an exemplar amino acid for several reasons. First, it is taken up by both Na+-dependent and Na+-independent mechanisms (Christensen 1985). Secondly, it is an essential amino acid, and may be rate limiting for growth. Thirdly, day 100 fetal plasma leucine concentrations are lower in the smallest fetus of the litter compared with a normal-sized littermate (C J Ashworth and H J McArdle, unpublished observations).
| Materials and Methods |
|---|
|
|
|---|
Preparation of placental membrane vesicles
Placental amino acid transporter function was investigated using an adaptation of a method used extensively to study uptake across the apical membrane of several species (McArdle et al. 1984, Dicke & Henderson 1988, Boyd 1991, Mahendran et al. 1993, Glazier et al. 1997, Jansson et al. 1998, Norberg et al. 1998). On homogenisation, the microvilli of the apical membrane form sealed vesicles that accumulate amino acids and other nutrients and reflect the transport characteristics of the placenta in situ.
Placental membrane vesicles were prepared from the freshly obtained fetal aspect of each placenta (consisting of trophoblast, connective tissue and allantoic layers) using an adaptation of previously published methods (McArdle et al. 1984). Placental tissue was placed in 150 mM NaCl, 5 mM Hepes (pH 7.4), chopped finely with scissors, washed twice in ice-cold 150 mM NaCl, 5 mM Hepes (pH 7.4), and then three times in 100 mM CaCl2, 5 mM Hepes (pH 7.4), followed by two washes in 250 mM sucrose, 20 mM Hepes (pH 7.4). The placental fragments were homogenised (13 000 r.p.m.) (30 s, 4 °C, x 3). The homogenate was centrifuged at 1500 g for 10 min, 15 000 g for 20 min and 105 000 g for 60 min. The pellet was discarded after the first two spins and the final pellet was resuspended in 10% sucrose and stored in aliquots at 70 °C. A sample of placenta was homogenised in 10% sucrose and kept for comparison with the vesicles. The purity of these membrane vesicle preparations was shown by enrichment of staining by the porcine trophoblast specific antibody SN1/38 (Whyte et al. 1984) on Western blots. Alkaline phosphatase is the standard measure of apical membrane enrichment. However, in early gestation it is not expressed in the pig placenta and in late pregnancy it only localises to discrete patches (Skolek-Winnisch et al. 1984). Therefore, vesicles were identified immunologically using the antibody SN1/38.
Immunoblotting
Placental vesicles were prepared as described above. Whole placental homogenate was prepared by homogenisation of placental tissue (consisting of trophoblast, connective tissue and allantoic layers) in 10% sucrose solution at a 1:5 w/v ratio. Protein concentration was determined by the Bradford assay (BioRad, Hemel Hempstead, Herts, UK) using BSA as a standard. Crude homogenate and placental vesicle preparations were resolved by SDS/PAGE (10% gel) in the presence of 5% v/v beta-mercaptoethanol as a reducing agent, and electroblotted to a nitrocellulose membrane. The monoclonal antibody SN1/38 (a gift from A Whyte, Babraham Institute, Cambridge, UK) was used (1:100). Immunoreactive species were detected with horseradish peroxidase-conjugated anti-mouse antibody (1:5000) using the enhanced chemiluminescence detection system (ECL; Amersham).
Immunohistochemistry
Fixed placentas were processed into wax blocks and sections (thickness, 5 µm) were cut for immunohistochemistry. Treatment with 3% hydrogen peroxide (Sigma, UK) in water (25 °C) quenched endogenous peroxidase activity. The samples were pretreated with a non-immune serum block (1.5% normal horse serum) for 20 min, and incubated with the SN1/38 antibody at a 1:400 dilution (made up in 1% BSA) overnight at 4 °C. Samples were again pre-treated with a non-immune serum block (1.5% normal horse serum; Vector Laboratories, Bretton, Peterborough, UK) and incubated for 30 min at 25 °C with 0.005% bio-tinylated mouse IgG diluted in 1.5% normal horse serum. Sections were labelled with the avidin-biotin-peroxidase detection system (Vector Laboratories). Thereafter, sections were counterstained with haematoxylin, dehydrated, and cleared in xylene. A matching concentration of mouse IgG was used as a negative control. Appropriate controls were prepared, omitting either primary or secondary antibody as necessary.
Vesicle transporter studies
L-Leucine uptake by microvillous membrane vesicles was determined by a modification of a rapid-filtration technique as described previously (McArdle et al. 1984). Briefly, 25 µg vesicle protein were incubated with 4.5 nM L-[4,5-3H] leucine (Amersham Life Science) in a balanced salt solution with or without Na+. The balanced salt solution consisted of 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 18 mM HEPES (pH 7.4) and 136 mM of either NaCl (Na+-buffer) or choline chloride (choline-buffer). In inhibition studies, unlabelled amino acids (2-amino-2-norbornane-carboxylic acid (BCH; Sigma), leucine or lysine) were added to the incubation buffer at the final concentrations indicated in the figure legends. BCH is a non-metabolised leucine analogue that is transported by system L (the transport system responsible for the sodium-independent transport of large neutral amino acids). The reaction was started by the addition of vesicles and stopped at 60 s by passing an aliquot (80 µl) through nitro-cellulose filters (Whatman, Brentford, Middlesex, UK) followed by two washes of 1 ml ice-cold incubation buffer. The filters were dissolved in 5 ml scintillation fluid (Ultima Gold, Packard Instrument Company, Meriden, CT, USA) and radioactivity was measured in a Packard beta counter. Appropriate blanks and standards were included as required.
Uptake, as opposed to binding, was measured by incubating vesicles in solutions of increasing osmolarity, achieved by the addition of mannitol, for 5 min by which time equilibrium was achieved (data not shown). Vesicle size (µl/mg protein) was calculated from the specific activity of the extra-vesicular medium.
Data analysis and expression of results
All uptake data were expressed as the difference between uptake at 39 °C and at 4 °C. The total and Na+-independent uptakes were defined as the uptake in the presence of sodium and choline respectively. Data were expressed as the uptake rate (fmol/s mg vesicle protein) or total placental uptake capacity. The total placental uptake capacity (fmol/s/placenta), an approximation of uptake capacity across the whole placenta, was derived from the uptake rate (fmol/s/mg vesicle protein) x placenta protein concentration (mg protein/placenta). No difference in protein concentration was seen between placentas (or the vesicles derived from them) supplying the low weight fetuses in comparison with those supplying the average-sized fetuses. Hence, total placental uptake capacity is a function of amino acid uptake and placental mass. Significance was determined via ANOVA and a post hoc Newman Keuls test, with the exception of the amino acid inhibition data for which significance was determined via ANOVA and Dunnets multiple comparison test.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Leucine transport across the trophoblast brush border of the placentas supplying the average sized fetuses, during early to mid gestation (day 45/65), is predominantly via system L, as demonstrated by the sodium-independent nature of uptake and its inhibition by BCH (Christensen 1985, Christensen et al., 1968). The particular system L transporter involved resembles the recently described LAT3 transporter (Babu et al. 2003). LAT3 mediates facilitated diffusion and does not require 4f2 for its function, unlike the obligatory exchangers LAT1 and LAT2 (Yanagida et al. 2001).
During late gestation, leucine uptake by the placenta supplying the average-sized fetus occurs by both sodium-independent and -dependent systems. The inhibition by BCH indicates that the sodium-independent component continues to be via system L. The sodium-dependent component can be identified as system B0 also by its inhibition by BCH and its inability to be inhibited by lysine (Stevens et al. 1982). System B0 (ASCT2) is present in late gestational rat placenta and in human placenta (Carbo et al. 1997, Knerr et al. 2003). In humans, ASCT2 is a dual function protein also acting as the receptor for syncytin. The expression of syncytin and ASCT2 are essential for the formation of the syncytium trophoblast layer (Frendo et al. 2003). However, in the pig placenta, in which a cellular trophoblast is maintained, the physiological significance of its expression in late gestation remains to be elucidated.
On day 45 placentas supplying small fetuses had a reduced leucine uptake capacity compared with those supplying average-sized fetuses. However, by day 65 there was no difference in either the rate or the total uptake capacity between the placentas, and this trend was continued at day 100. There was, however, a difference in the proportion of the transport systems used. The placentas derived from the average-sized fetus utilised both sodium-independent and -dependent systems, while the placentas supplying the smallest fetuses continued to use the sodium-independent system L. It is not clear whether placentas supplying low weight fetuses are developmentally delayed and would show system B0 activity later in gestation or if this switch to system B0 transport never occurs in these placentas.
We have demonstrated that approximately one third of pig litters contain fetuses classified as intra-uterine growth retarded (IUGR) on the basis that they are outliers in an otherwise normally distributed population within the uterus (Finch et al. 2002). Although it was outside the scope of the present study, it will be important to determine how the observed differences in placental nutrient transport are manifest during IUGR. The full implications of the altered amino acid transport in placentas supplying small fetuses require further investigation.
The forces driving these changes in amino acid transporter expression need to be elucidated. It can be speculated that these changes in amino acid transporter expression are not driven by the placenta but are a consequence of the low fetal weight, as low weight fetuses can be identified in pig litters as early as day 30 of pregnancy (van der Lende et al. 1990, Finch et al. 2002). Low levels of epidermal growth factor (EGF) in amniotic fluid are associated with IUGR (Varner et al. 1996) and the expression of ASCT2 (system B0) has been shown to be stimulated by EGF (Torres-Zamorano et al. 1997). This may be the mechanism behind the lack of system B0 seen in the placentas supplying the low weight fetuses.
In conclusion, this study has demonstrated that the porcine placenta shows similar transport systems for neutral amino acids as those of other species (Carbo et al. 1997, Jansson et al. 1998) with the presence of system L, and later in gestation, system B0 transport across the brush border trophoblast membrane of the normal porcine placenta. In placentas associated with small fetuses, system L transport is present throughout pregnancy and system B0 is absent.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Ashworth CJ, Finch AM, Page KR, Nwagwu MO & McArdle HJ 2001 Causes and consequences of fetal growth retardation in pigs. Reproduction Supplement 58 233246.
Babu E, Kanai Y, Chairoungda A, Kim DK, Iribe Y, Tangtrongsup S, Jutabha P, Li Y, Ahmed N, Sakamotto S, Anzai N, Nagamori S & Endou H 2003 Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. Journal of Biological Chemistry 278 4383843845.
Boyd CA 1991 Placental transport studied by means of isolated plasma membrane vesicles. Proceedings of the Nutrition Society 50 337343.[CrossRef][ISI][Medline]
Carbo N, Lopez-Soriano FJ & Argiles JM 1997 Neutral amino acid transport in placental plasma membrane vesicles in the late pregnant rat. Evidence for a B0-like transport system. European Journal of Obstetrics, Gynecology and Reproductive Biology 71 8590.[CrossRef][ISI][Medline]
Christensen HN 1985 On the strategy of kinetic discrimination of amino acid transport systems. Journal of Membrane Biology 84 97103.[CrossRef][ISI][Medline]
Christensen HN, Handlogten ME, Lam I, Tager HS & Zand R 1968 A bicyclic amino acid to improve discriminations among transport systems. Journal of Biological Chemistry 244 15101520.[ISI]
Cooper JE 1975 The use of the pig as an animal model to study problems associated with low birthweight. Laboratory Animals 9 329336.
Dicke JM & Henderson GI 1988 Placental amino acid uptake in normal and complicated pregnancies. American Journal of Medical Science 295 223227.[CrossRef]
Finch AM, Antipatis C, Pickard AR & Ashworth CJ 2002 Patterns of fetal growth within Large White x Landrace and Chinese Meishan gilt litters at three stages of gestation. Reproduction, Fertility and Development 14 419425.[CrossRef][Medline]
Frendo JL, Olivier D, Cheynet V, Blond JL, Bouton O, Vidaud M, Rabreau M, Evain-Brion D & Mallet F 2003 Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Molecular Cell Biology 23 35663574.
Glazier JD, Cetin I, Perugino G, Ronzoni S, Grey AM, Mahendran D, Marconi AM, Pardi G & Sibley CP 1997 Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatric Research 42 514519.[ISI][Medline]
Godfrey KM & Barker DJ 2000 Fetal nutrition and adult disease. American Journal of Clinical Nutrition 71 1344S1352S.
Jansson T, Scholtbach V & Powell TL 1998 Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatric Research 44 532537.[ISI][Medline]
Knerr I, Weigel C, Linnemann K, Dotsch J, Meissner U, Fusch C & Rascher W 2003 Transcriptional effects of hypoxia on fusiogenic syncytin and its receptor ASCT2 in human cytotrophoblast BeWo cells and in ex vivo perfused placental cotyledons. American Journal of Obstetrics and Gynecology 189 583588.[CrossRef][ISI][Medline]
van der Lende T, Hazeleger W & de Jager D 1990 Weight distribution within litters at the early foetal stage and at birth in relation to embryonic mortality in the pig. Livestock Production Science 26 5365.[CrossRef]
McArdle HJ, Douglas AJ & Morgan EH 1984 Transferrin binding by microvillar vesicles isolated from rat placenta. Placenta 5 131138.[CrossRef][ISI][Medline]
Mahendran D, Donnai P, Glazier JD, DSouza SW, Boyd RD & Sibley CP 1993 Amino acid (system A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small-for-gestational-age babies. Pediatric Research 34 661665.[ISI][Medline]
Norberg S, Powell TL & Jansson T 1998 Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Pediatric Research 44 233238.[ISI][Medline]
Ross JC, Fennessey PV, Wilkening RB, Battaglia FC & Meschia G 1996 Placental transport and fetal utilization of leucine in a model of fetal growth retardation. American Journal of Physiology. Endocrinology and Metabolism 33 E491E503.
Sibley C, Glazier J & DSouza S 1997 Placental transporter activity and expression in relation to fetal growth. Experimental Physiology 82 389402.[Abstract]
Skolek-Winnisch R, Lipp W, Sinowatz F & Friess AE 1984 Enzyme histochemical studies of the swine placenta. Histoptics of enzymes in interareolar placental epithelia. Acta Histochemica 74 195207.[ISI][Medline]
Stevens BR, Ross HJ & Wright EM 1982 Multiple transport pathways for neutral amino acids in rabbit jejunal brush border vesicles. Journal of Membrane Biology 66 213225.[CrossRef][ISI][Medline]
Torres-Zamorano V, Kekuda R, Leibach FH & Ganapathy V 1997 Tyrosine phosphorylation- and epidermal growth factor-dependent regulation of the sodium-coupled amino acid transporter B0 in the human placental choriocarcinoma cell line JAR. Biochimica et Biophysica Acta 1356 258270.[Medline]
Varner MW, Dildy GA, Hunter C, Dudley DJ, Clark SL & Mitchell MD 1996 Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies. Journal of the Society for Gynecologic Investigation 3 1719.[CrossRef][ISI][Medline]
Whyte A, Bacon M & Ellis S 1984 A monoclonal antibody to an antigen present on the microvillous membrane of the trophectoderm of the preimplantation blastocyst of the pig. Journal of Reproduction and Fertility 71 599605.
Winters LM, Cummings JN & Stewart HA 1947 A study of factors affecting survival from birth to weaning and total weaning weight of the litter of swine. Journal of Animal Science 6 288296.
Wootton R, MacFadyen IR & Cooper JE 1977 Measurement of placental blood flow in the pig and its relationship to placental and fetal weight. Biology of the Neonate 31 333339.[ISI][Medline]
Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, Cha SH, Matsuo H, Fukushima J, Fukasawa Y, Tani Y, Taketani Y, Uchino H, Kim JY, Inatomi J, Okayasu I, Miyamoto K, Takeda E, Goya T & Endou H 2001 Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochimica et Biophysica Acta 1514 291302.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |